Prominent cardiologist joins RBM's Scientific Advisory Board.
"Press Release
Response Biomedical Appoints UNC Chief Of Cardiology To Scientific Advisory Board
VANCOUVER, BRITISH COLUMBIA--Response Biomedical Corp. (RBM:CDNX) today announced the appointment of E. Magnus Ohman, MB, FRCPI, FACC to the Company's Scientific Advisory Board (``SAB''). Dr. Ohman, Chief of Cardiology and Director of the Heart Center at the Univeristy of North Carolina (``UNC''), is an expert in acute coronary care and consultative cardiology.
``As a practicing cardiologist, I have seen the positive effects rapid diagnosis of a heart attack can have on patient outcome'', said Dr. Ohman. ``I look forward to the opportunity of working with Response Biomedical and the other members of the SAB to maximize the potential of the RAMPTM System and provide direction for future RAMP applications.''
Prior to his appointment at UNC, Dr. Ohman spent 10 years as a faculty member in the Division of Cardiology at Duke University Medical Center. He is a Fellow of the Royal College of Physicians, Royal Society of Medicine, European Society of Cardiology, American College of Cardiology and the Society for Cardiac Angiography and Interventions. A Professor of Medicine at UNC, Dr. Ohman's research activities have covered a number of areas in cardiology and he has contributed over 300 articles, abstracts, book chapters, and invited presentations to the medical press. He currently serves as Associate Editor for the American Heart Journal, and is a member of the Editorial Boards of the American Journal of Cardiology, the Canadian Journal of Cardiology, and Expert Opinion on Pharmacotherapy.
``It is further validation of RAMP's potential that someone of Dr. Ohman's calibre has joined our SAB'', said Bill Radvak, President & CEO of Response Biomedical. ``His extensive medical experience in the field of cardiology and his vision of the future of point-of-care testing will be a great asset to the Company.'' |
